Stocks
Cortexyme () ROE US GAAP (year values) |
||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | |||
| ROE, % | ? | 60.3% | -17.5% | -32.0% | -44.6% | -75.8% | -134.4% | |
| Changes by years, y/y, % | -78pp | -15pp | -13pp | -31pp | ||||
Cortexyme. ROE, %
Cortexyme. ROE, changes, pp
Cortexyme () ROE US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| ROE, % | ? | -61.2% | -65.7% | -132.0% | -145.8% | -134.4% | -134.4% | |
| Changes by years, y/y, % | -33pp | -29pp | -87pp | -93pp | -73pp | |||
| Changes by quarters, q/q, % | -8pp | -4pp | -66pp | -14pp | +11pp | |||
